Alto Neuroscience, Inc.
Biotechnology
Healthcare
ANRO
27.05 M shares
NYSE US
traded
23 Sep 2025
listed
no
open
4.00
52 week high
14.53
high
4.14
52 week low
0.00
previous Close
3.98
P/E ratio
market cap
84.46 M
div yield
0
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top